Immunization: Mind the gap

Vaccine

Volumn 26, Issue 52, 2008, Pages 6736-6737

  Jagessar, Naroesha ^a   Lazarus, Jeffrey V ^a   Laurent, Eric ^a   Matic, Srdan ^a   Emiroglu, Nedret ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Equity; Europe; Health promotion; Immunization

Indexed keywords

EDITORIAL; EUROPE; HEALTH PROGRAM; HEALTH PROMOTION; IMMUNIZATION; INFECTION PREVENTION; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; EUROPE; HEALTH EDUCATION; HUMANS; IMMUNIZATION; PRIMARY PREVENTION; PUBLIC HEALTH; VACCINES;

EID: 56649083637     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.087     Document Type: Editorial

References (15)

1. WHO Global Vaccine Research Forum 2008, Paris; June 29-July 2, 2008. http://www.who.int/vaccine_research/about/gvrf/2008/en/index.html [accessed June 26, 2008].
2. Guerra F.A. Delays in immunization have potentially serious health consequences. Paediatr Drugs 9 3 (2007) 143-148
3. Falagas M.E., and Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin 24 6 (2008) 1719-1741
4. Kimman T.G., Boot H.J., Berbers G.A., Vermeer-de Bondt P.E., Ardine de Wit G., and de Melker H.E. Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs. Vaccine 24 May (22) (2006) 4769-4778
5. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokure B., Hawker J., et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 24 February (8) (2006) 1047-1062
6. Thompson K.M., Tebbens R.J., Pallansch M.A., Kew O.M., Sutter R.W., Aylward R.B., et al. The risks, costs, and benefits of possible future global policies for managing polioviruses. Am J Public Health 98 7 (2008) 1322-1330
7. (No authors listed). Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. MMWR Recomm Rep 1997; 46(Jun 13 (RR-11)):1-20.
8. de Quadros C.A., Andrus J.K., Danovaro-Holliday M.C., and Castillo-Solórzano C. Feasibility of global measles eradication after interruption of transmission in the Americas. Exp Rev Vaccines 7 3 (2008) 355-362
9. Morgan O.W. Following in the footsteps of smallpox: can we achieve the global eradication of measles?. BMC Int Health Hum Rights 4 Mar (1) (2004) 1
10. Madhi S.A., Levine O.S., Hajjeh R., Mansoor O.D., and Cherian T. Vaccines to prevent pneumonia and improve child survival. Bull World Health Organ 86 5 (2008) 365-372
11. Centralized information system for infectious diseases (CISID). http://data.euro. who.int/cisid/ [accessed July 1, 2008].
12. Gangarosa E.J., Galazka A.M., Wolfe C.R., Phillips L.M., Gangarosa R.E., Millar E., et al. Impact of anti-vaccine movements on pertussis control: the untold store. Lancet 351 9099 (1998) 356-361
13. WHO Regional Office for Europe. Immunization and the paradox of success. Copenhagen April 21, 2008; http://www.euro.who.int/mediacentre/PR/2008/[20080421_1] [accessed June 30, 2008].
14. European Immunization Week (EIW). http://www.euro.who.int/eiw [accessed June 30, 2008].
15. Fine P.E.M. Herd immunity: history, theory, practice. Epidemiol Rev 15 2 (1993) 265-302